Spadge Vernacular
Player Valuation: £70m
The current studies that are causing alarm are exactly because of the South African mutation in its features (spike protein) that our immune response targets. There is now evidence of reducing the immune response, even confirmed reinfections.That's efficacy in terms of stopping infection. The very next paragraph details the T-cell response which is strong.
As said, variants will evade vaccine efficacy, but there's no evidence it evades the immunogenic response.
As wonderful as it is that it appears that the vaccines are having a positive impact on serious infection, any infected or reinfected host is a reservoir for further mutation. The initial findings of the studies mentioned, though not conclusive at this point have raised real concerns due to the possibility of a running battle in which we are playing catch up with vaccination/boosters and potentially more dangerous mutations.
We should have suppressed and controlled the virus to give the vaccination programme its best shot but we didn't. We still can though if the will is there.
